SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum CAMBRIDGE, Mass., Oct. 16, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2019 BIO [...]
Jose Trevejo, MD, PhD, will present at the 2019 BIO Investor Forum
We will be presenting on October 7th at 8:00 AM (ET) at Chardan's 3rd Annual Genetic Medicines Conference. Chardan's annual Genetic Medicines Conference is the largest sell-side conference focused exclusively on advancing the field of genetic medicines. Now in its 3rd year, this expanded one and half day conference brings together executives from more [...]
We will be at the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease CompaniesCompanies, New York, NY, September 23-24 The summit features one-on-one meetings with a select group companies focused on specialty pharma and orphan and rare disease. Investors will have the opportunity to meet with management teams to discuss in detail [...]
SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference CAMBRIDGE, Mass. – September 30, 2019 – SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, President and Chief Executive Officer, will present [...]
SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors Published: Sep 05, 2019 CAMBRIDGE, Mass., Sept. 5, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of Fred Driscoll to its Board of Directors. Mr. [...]
Join us at the EWGGD We will be at EWGGD 2019 on July 4-6, 2019. Come find us or better yet call and schedule an appointment to meet us!
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer CAMBRIDGE, Mass. – June 25, 2019 – SmartPharm Therapeutics, a pre-clinical stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, has been appointed Chief Executive Officer. Dr. [...]
